Leads from the MMWR. Recommendations for protection against viral hepatitis.
出版信息
JAMA. 1985 Jul 12;254(2):197-8, 203-5, 210-1 passim.
PMID:3158759
Abstract
摘要
相似文献
1
Leads from the MMWR. Recommendations for protection against viral hepatitis.来自《发病率与死亡率周报》。预防病毒性肝炎的建议。
JAMA. 1985 Jul 12;254(2):197-8, 203-5, 210-1 passim.
2
[Round table and a multidisciplinary discussion].[圆桌会议与多学科讨论]
Rev Med Liege. 1984 Oct 15;39(20):722-40.
3
Modern vaccines. Hepatitis.现代疫苗。肝炎。
Lancet. 1990 May 12;335(8698):1142-5. doi: 10.1016/0140-6736(90)91138-z.
4
5
Viral hepatitis: A, B, C, D, and E--prevention.病毒性肝炎：甲型、乙型、丙型、丁型和戊型——预防
Pediatr Rev. 1992 Jul;13(7):245-7. doi: 10.1542/pir.13-7-245.
6
Preventing the spread of viral hepatitis.预防病毒性肝炎的传播。
Am Fam Physician. 1993 Dec;48(8):1479-86.
7
8
Viral hepatitis. Questions and answers.病毒性肝炎。问答
Trop Doct. 1986 Jul;16(3):99-104. doi: 10.1177/004947558601600303.
9
[Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].[53名高危儿童接种疫苗预防乙型肝炎。乙型肝炎病毒感染的传播及其预防]
Minerva Pediatr. 1985 Sep 15;37(17):593-6.
10
Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP).预防病毒性肝炎。免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 1990 Feb 9;39(RR-2):1-26.
引用本文的文献
1
Molecular mechanism of CAIF inhibiting myocardial infarction by sponging miR‑488 and regulating AVEN expression.CAIF 通过海绵吸附 miR-488 并调控 AVEN 表达抑制心肌梗死的分子机制。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12786. Epub 2022 Jul 7.
2
Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines.建立乙肝病毒出生剂量疫苗接种的证据基础：证据图谱及系统评价与指南的批判性评估
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):375-381. doi: 10.1002/cld.1103. eCollection 2021 May.
Zotero 插件